Patent Assignment
Reel/Frame 014455/0058
Corrective Assignment to Correct the Assignee Address. Document Previously Recorded on Reel 013758 Frame 0551, Assignor Confirms the Assignment of the Entire Interest.
Recorded: 2003-09-09
Pages: 21
Assignor
KNOLL AKTIENGESELLSCHAFT
Executed: 2001-11-22
Assignee
ABBOTT GMBH & CO. KG
MAX-PLANCK-RING 2, WIESBADEN, GERMANY
Covered Properties
(40)
Stable Emulsion Suitable for Pharmaceutical Administration, the Production Thereof and Emulsion for Pharmaceutical Use
Patent:
5,496,818 →
Application:
08/057,553 →
Resolution of 5-Methyltetrahydrofolic Acid
Patent:
5,457,202 →
Application:
08/232,267 →
Resolution of Racemic Verapamil
Patent:
5,457,224 →
Application:
08/244,681 →
Novel Asymmetrically Substituted Bisnaphthalimides
Patent:
5,554,622 →
Application:
08/397,259 →
Preparation of Colloidal Aqueous Solutions of Active Substances of Low Solubility and a Lipid Therefor
Patent:
5,720,973 →
Application:
08/492,006 →
The Preparation of Colloidal Aqueous Solutions of Active Substances of Low Solubility
Patent:
5,626,864 →
Application:
08/495,597 →
Delayed Release Microtablet of Beta-Phenylpropiophenone Derivatives
Patent:
5,681,588 →
Application:
08/525,749 →
Composition of S(-) Sodium Ibuprofen
Patent:
5,696,165 →
Application:
08/557,565 →
Condensed 4-Aminopyridines with Antirheumatic Activity
Patent:
5,780,482 →
Application:
08/564,154 →
Azolyl-Cyclic Amine Derivates with Immunomodulatory Activity
Patent:
5,741,800 →
Application:
08/564,155 →
Isoquinoline Derivatives as Therapeutic Agents
Patent:
5,807,868 →
Application:
08/564,156 →
Bicyclic Aromatic Compounds as Therapeutic Agents
Patent:
5,767,116 →
Application:
08/605,130 →
Therapeutic Agents
Patent:
5,760,035 →
Application:
08/615,202 →
Therapeutic Agents Containing Thyroid Hormones
Patent:
5,753,254 →
Application:
08/682,783 →
Use of Anti-Tnf Antibodies as Drugs for the Treatment of Disorders with an Elevated Serum Level of Interleukin-6
Patent:
6,235,281 →
Application:
08/687,328 →
Naphthyridine Derivatives
Patent:
5,712,286 →
Application:
08/809,581 →
Process for Producing Sodium 1-Thyroxine Comprising the Oxidative Coupling of a Diido-1-Tyrosine Catalysed by a Manganese Salt in the Presence of an Amine
Patent:
5,917,087 →
Application:
08/817,325 →
Preparation of Colloidal Aqueous Solutions of Active Substances of Low Solubility and a Lipid Therefor
Patent:
5,849,941 →
Application:
08/902,733 →
Aryl Substituted Cyclobutyl Alkyl Amines for the Treatment of Obesity
Patent:
6,127,424 →
Application:
08/952,285 →
Particles with Modified Physicochemical Properties, Their Preparation and Uses
Patent:
6,197,349 →
Application:
08/968,899 →
Heterocyclcarboxamide Deritvatives and Their Use as Therapeuctic Agents
Patent:
5,935,973 →
Application:
08/981,671 →
Phenooxy-,Phenylthio-,Benzoyl-Alkyleneaminoalkylene -Imidazole Derivativesas Therapeutic Agents
Patent:
6,031,109 →
Application:
09/050,396 →
Heteroarylcarboxamide Derivatives for Treating Cns Disorders
Patent:
6,107,310 →
Application:
09/091,129 →
Method of Purifying Thrombin-Like Protease Enzymes Obtained from Snake Venom
Patent:
6,200,791 →
Application:
09/125,374 →
Method for Establishing a Dosage Plan for Thrombin Inhibitors
Use of Aryl-Substituted Cyclobutylalkylamines for Treating Urinary Incontinence
Patent:
6,046,242 →
Application:
09/201,309 →
Therapeutic Agents
Organoprotective Solutions
Patent:
6,313,104 →
Application:
09/235,235 →
Process for the Preparation of 7-Alkoxyalkyl-1,2,4-Triazolo[1,5-a]Pyrimidine Derivatives
Patent:
6,225,469 →
Application:
09/242,465 →
Use of Sibutramine Analogues to Prevent the Development of Diabetes
Patent:
6,174,925 →
Application:
09/254,924 →
Medical Treatment to Lower Uric Acid Levels
Patent:
6,162,831 →
Application:
09/269,339 →
Medical Treatment to Improve Lipid Levels
Patent:
6,187,820 →
Application:
09/269,340 →
Sulfonamide Compounds Having 5-Ht Receptor Activity
Patent:
6,136,825 →
Application:
09/331,066 →
Imidazole Derivatives as Therapeutic Agents
Patent:
6,215,001 →
Application:
09/415,516 →
Endothelin Antagonist and Beta Receptor Blocking Agent as Combined Preparations
Patent:
6,352,992 →
Application:
09/508,989 →
Endothelin Antagonist and a Renin-Angiotensin System Inhibitor as a Combined Preparation
Patent:
6,329,384 →
Application:
09/508,993 →
Novel Pharmaceutically Active Compounds, Their Preparation and Use as Ece-Inhibitors
Patent:
6,469,056 →
Application:
09/529,181 →
Carboxylic Acid Derivatives, Carrying Amido Side-Chains; Production and Use as Endothelin Receptor Antagonists
Patent:
6,509,341 →
Application:
09/529,860 →
Method for Combating Obesity
Patent:
6,197,780 →
Application:
09/530,131 →
Imidazole Derivatives for Blocking the Release of Arachidonic Acid from Phospholipids
Patent:
6,326,500 →
Application:
09/748,008 →
Related Assignments
(16)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 31, 1996
From: KHAN, KARRAR AHMAD; SMITH, ALAN
To: KNOLL AKTIENGESELLSCHAFT
Reel/Frame 008173/0526 →
Assignment of Assignor's Interest
Sep 11, 1996
From: STENZEL, ROSWITHA; KAUL, MARTIN; DAUM, LOTHAR; KEMPENI, JOACHIM
To: BASF AKTIENGESELLSCHAFT
Reel/Frame 008127/0897 →
Change of Name
Sep 9, 2003
From: KNOLL AKTIENGESSELLSCHAFT
To: ABBOTT GMBH & CO. KG
Reel/Frame 014446/0831 →
Assignment of Assignor's Interest
Jan 21, 2004
From: ABBOTT GMBH & CO. KG
To: ABBOTT LABORATORIES
Reel/Frame 014901/0679 →
Assignment of Assignor's Interest
Jan 21, 2004
From: ABBOTT LABORATORIES
To: RELIANT PHARMACEUTICALS, LLC
Reel/Frame 014910/0543 →
Security Agreement
Sep 8, 2004
From: RELIANT PHARMACEUTICALS, INC.
To: CREDIT SUISSE FIRST BOSTON
Reel/Frame 015116/0592 →
Security Agreement
Sep 27, 2004
From: RELIANT PHARMACEUTICALS, INC.
To: CREDIT SUISSE FIRST BOSTON
Reel/Frame 015810/0418 →
Security Interest
Apr 18, 2005
From: RELIANT PHARMACEUTICALS, INC.
To: BANK OF NEW YORK, THE
Reel/Frame 016460/0713 →
Security Agreement
May 9, 2007
From: RELIANT PHARMACEUTICALS, INC.
To: GOLDMAN SACHS CREDIT PARTNERS, L.P., AS COLLATERAL AGENT
Reel/Frame 019265/0086 →
Assignment of Assignor's Interest
Apr 17, 2008
From: ABBOTT GMBH & CO. KG
To: MSE PHARMAZEUTIKA GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG
Reel/Frame 020817/0133 →
Release of Security Interest
Jul 26, 2010
From: GOLDMAN SACHS CREDIT PARTNERS L.P., AS COLLATERAL AGENT
To: RELIANT PHARMACEUTICALS, INC.
Reel/Frame 024741/0060 →
Change of Name
Apr 13, 2012
From: RELIANT PHARMACEUTICALS, INC.
To: GLAXOSMITHKLINE LLC
Reel/Frame 028041/0742 →
Assignment of Assignor's Interest
Dec 19, 2012
From: ABBOTT GMBH & CO. KG
To: NORDMARK HOLDING GMBH
Reel/Frame 029503/0247 →
Assignment of Assignor's Interest
Jul 9, 2013
From: ABBOTT GMBH & CO KG
To: ABBVIE DEUTSCHLAND GMBH & CO KG
Reel/Frame 030763/0308 →
Assignment of Assignor's Interest
Jul 16, 2013
From: ABBOTT GMBH & CO KG
To: ABBVIE DEUTSCHLAND GMBH & CO KG
Reel/Frame 030805/0023 →
Assignment of Assignor's Interest
Jul 16, 2013
From: ABBOTT GMBH & CO KG
To: ABBVIE DEUTSCHLAND GMBH & CO KG
Reel/Frame 030804/0429 →